why choose us

First received: March 14, 2023

Clinical Trial: Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alopecia, Androgenetic

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Vehicle-controlled, Parallel Group, Multi-dose Study to Evaluate the Efficacy and Safety of TDM-105795 in Male Subjects With Androgenetic Alopecia

Brief Summary: Randomized, double-blind, vehicle-controlled, parallel group, multi-dose study of TDM-105795 in male subjects with androgenetic alopecia

Read more